XENE
Xenon Pharmaceuticals Inc

2,577
Loading...
Loading...
News
all
press releases
Why Is Xenon Pharmaceuticals (XENE) Up 4.2% Since Last Earnings Report?
Xenon Pharmaceuticals (XENE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·23d ago
News Placeholder
More News
News Placeholder
Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus
XENE's wider Q2 loss highlights its push toward late-stage epilepsy, depression, and bipolar disorder studies with azetukalner.
Zacks·2mo ago
News Placeholder
Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit
The company anticipates a research expense in Q2 associated with milestone and licensing payments, which will impact both GAAP and non-GAAP earnings per share.
Stocktwits·3mo ago
News Placeholder
Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue?
Zacks·4mo ago
News Placeholder
Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus
Zacks·5mo ago
News Placeholder
Deutsche Bank initiates coverage of biopharma stocks, sees 'modest recovery'
Investing.com -- Deutsche Bank initiated coverage on 11 U.S. biopharma stocks in a note Tuesday, assigning Buy ratings to eight companies and Hold ratings to three. 
investing.com·8mo ago
News Placeholder
Earnings Preview: Xenon Pharmaceuticals
read more...
Benzinga·11mo ago
News Placeholder
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will...
Globe Newswire·1y ago
News Placeholder
Xenon Pharmaceuticals (XENE, $42.15) Stochastic Oscillator left the oversold zone on April 01, 2024
This is a signal that XENE's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
Tickeron - Stocks·2y ago
News Placeholder
Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)
Xenon Pharmaceuticals Inc. (NASDAQ:XENE Get Free Report) was the target of some unusual options trading on Wednesday. Stock investors bought 4,063 put options on the stock. This represents an...
Ticker Report·2y ago

Latest XENE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.